Newsroom
Healthcare Execs Try to Be Optimistic About ICD-10
Despite numerous delays and the difficulty of preparing for ICD-10, there are reasons to be optimistic for the transition, according to the results of a new survey.
CDC Identifies Need to Improve Cervical Cancer Screening
Ileana Arias, PhD, CDC principal deputy director, recommends active screening by Pap test and HPV test, and vaccination of young boys and girls to improve early detection and prevention rates.
FDA Approves Ramucirumab Plus Paclitaxel for Advanced Gastric Cancer
The drug combination showed a significant improvement of 2.2 months in OS compared to the placebo arm.
Meaningful Use Numbers Disappointing But Not Surprising
Recently released numbers from the CMS Meaningful Use program were lower than expected, which further highlights the changes that need to be made in meeting federal guidelines for electronic health record requirements, according to officials 4 healthcare organizations.
Patient Hand-Off Tool Reduces Medical Error-Driven Injuries
The study, published in the New England Journal of Medicine, found that using the I-PASS communication system for patient hand-off between providers significantly reduced patient injuries due to medical errors.
Renewed Efforts to Target the Ras Protein in Cancer
Despite decades of efforts to target the Ras protein, mutated in a number of different cancers, the progress has been slow. Now, scientists at the Max Planck Institute of Molecular Physiology in Germany have devised a way to prevent translocation of Ras to the cell surface, a process essential for protein activation.
Insurance Rate Initiative Defeated in California
Healthcare reform initiatives may be on shaky ground after Republicans won important seats this midterm election, but health reform advocates are claiming victory in California after defeating an insurance rate initiative.
Significant Survival Advantage Combining Ipilimumab With an Immune Booster in Metastatic Melanoma
The study, published in JAMA, found a 50% improvement in survival in patients with metastatic melanoma who were treated with ipilimumab, if they simultaneously received an immune stimulant.
Obama Admin Goes After Plans that Lack Hospital Coverage
Large employer health plans will now be required to cover in-patient hospitalization services, according to a notice from the Treasury Department and HHS on Tuesday morning. The final regulation will be issued next year.
COTA and Foundation Medicine Collaboration Will Further Value-Based Cancer Care
COTA will expand Foundation Medicine’s molecular information knowledge base with longitudinal clinical outcomes and cost of care data and analytics.
Amgen's Ovarian Cancer Drug Fails to Improve OS
Trebananib combined with paclitaxel improved survival by a month compared to the placebo, from 18.3 months to 19.3 months.
Global Budget Payment Model Lowers Spending, Improves Care Over 4 Years
Using global budgets for healthcare instead of traditional fee-for-service improves quality of patient care and lowers costs, according to a new study by researchers from Harvard Medical School’s Department of Health Care Policy.
WHO Chief Blames Pharma For Neglecting Poorer Nations
According to Margaret Chan, the Director-General of the WHO, "A profit-driven industry does not invest in products for markets that cannot pay."
Biosimilars a Big Cost Saver, RAND Study Finds
The study by Andrew Mulcahy, a policy researcher at the RAND Corporation, found that the predicted $44 billion saving to the US healthcare system over the next decade, would depend on FDA decisions on newer biosimilar drug candidates.
Generics May Improve Adherence in Breast Cancer Patients, Study Finds
The study, published in the Journal of the National Cancer Institute, found that out-of-pocket costs influenced adherence to hormone therapy in women with HR-positive, early-stage breast cancer.
The Industry’s Dirty Secret: The Data Are Inaccurate
Patient satisfaction may be increasingly important in healthcare, but the industry hasn’t made the appropriate changes yet, 2 employees from Prime Therapeutics said in back-to-back sessions at the 64th Annual Roy A. Bowers Pharmaceutical Conference.
Myriad and Abbvie Deal on Companion Diagnostic Test for Breast Cancer
The BRCAnalysis test will be used in conjunction with Abbvie's novel PARP inhibitor veliparib for the treatment of breast cancer.
In the Literature: microRNA Biomarkers For Early Detection of Childhood Cancers
Research to be presented this week at the National Cancer Research Institute Cancer Conference has identified the expression of specific serum microRNAs in pediatric solid tumors, which could prove useful for early diagnosis.
Supreme Court Passes on ACA Subsidy Case—For Now
At this time, the Supreme Court of the United States has declined to hear an appeal of one of the cases challenging the legality of making subsidies under the Affordable Care Act available to consumers on the federally run health insurance exchanges.
Physician Fee Schedule and Hospital Outpatient Payment System: Updates by CMS
CMS released final rules for both the 2015 Medicare Physician Fee Schedule and the 2015 Hospital Outpatient Prospective Payment System.
Limited Literacy, Numeracy Hurts Those the ACA Is Meant to Help
The Affordable Care Act expanded healthcare coverage to many low-income Americans, but this same demographic has a low health literacy that makes it difficult for them to navigate program eligibility systems, according to a study from The Urban Institute.
California Data Breach Report Underscores Need for Encryption in Healthcare
Seventy percent of breaches involving the California healthcare industry were due to unencrypted data on lost or stolen hardware or portable media, a problem that strong encryption would fix.
Computer-Aided Mammograms Increase Medicare Cost-Burden: JAMA Study
The retrospective study analyzed SEER data from 2001 through 2009, and found that the annual CAD prevalence among Medicare screening mammograms increased from 3.5% to 79.7%.
Diagnostic Lung Biopsies a Big Drain on Medicare, Study Finds
The retrospective study, results of which were presented at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, showed that the total diagnostic workup cost for the study sample of Medicare beneficiaries was $38.3 million.
Medicare Budget Pinched By Payments for the Departed
An investigation into 2012 Medicare claims for HIV-infected patients unearthed payment for prescriptions that were filled up to 32 days after the patient's passing.